Case-Based Roundtable
General Dermatology
Eczema
Chronic Hand Eczema
Chronic Spontaneous Urticaria
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis
Buy-and-Bill

Video

May 26, 2022

Drug Watch: What's Coming in Acne Treatment?

Author(s):

In this drug pipeline interview, Christopher Bunick, MD, PhD, discusses what is innovative in future acne treatment options, what research is happening, and what potential approvals the dermatology space has to look forward to.

Christopher Bunick, MD, PhD, Dermatology Times® editorial board member and physician-scientist practicing general medical and surgical dermatology at Yale University, in New Haven, Connecticut, dives into the acne drug pipeline. Hear his notes on what potenital new treatments are coming for acne vulgaris, exciting research advancements in the space, and much more.

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!